Bacterial Infection Identified as Cause of Overactive Bladder Syndrome
By LabMedica International staff writers Posted on 28 Jul 2016 |
Image: The DM4000 B automated LED microscope system (Photo courtesy of Leica Microsystems).
Overactive Bladder (OAB) is currently characterized by symptoms of urgency, with or without urgency incontinence, with increased frequency, and nocturia, and in some cases pain, in the absence of urinary tract infection (UTI) or other defined underlying pathology.
The exclusion of infection is determined by failure to isolate more than 105 colony forming units (CFU)/mL of a single species of bacteria from culture of a midstream urine (MSU) specimen and negative leukocyte esterase and/or nitrate urinalysis by dipstick.
Scientists at the University of Kent (Chatham, UK) obtained bladder biopsies from local hospitals, and a catheter specimen of urine (CSU) was obtained from female patients and a MSU from male patients and non-OAB controls. All urine samples obtained were sent for conventional urinalysis and bacteria culture at the time of collection, if a UTI was subsequently identified the sample was retrospectively removed from the study.
The bladder biopsies were sectioned and stained and the morphological characteristics of the tissue evaluated. A DM4000B upright light microscope (Leica, Wetlar, Germany) was used to image the sections. A Luciferin Luciferase Adenosine triphosphate (ATP) Bioluminiscence Assay Kit was used to quantify ATP release from intact, live, bladder urothelium. ATP-evoked luminescence was quantified using a Synergy 2 luminometer (BioTek, Winooski, USA). The scientists also performed biopsy vesicle staining, biopsy ribonucleic acid (RNA) extraction and polymerase chain reactions, urine sediment immunofluorescence and urine nucleotide and nucleoside quantification.
The team found that some OAB patients had a low-grade inflammation, which is missed by conventional tests. This low-grade inflammation may ultimately result in increased sensory nerve excitation and the symptoms of OAB. They also found that in these patients the low-grade inflammation is associated with bacteria living inside the bladder wall. This was an observational study which means that no conclusions can be drawn about cause and effect. However, the findings may prompt the clinical re-classification of OAB and inform future therapeutic strategies. These might include protracted treatment with antibiotics to alleviate the symptoms of OAB in some individuals. The study was published on June 29, 2016, in the American Journal of Physiology.
Related Links:
University of Kent
Leica
BioTek
The exclusion of infection is determined by failure to isolate more than 105 colony forming units (CFU)/mL of a single species of bacteria from culture of a midstream urine (MSU) specimen and negative leukocyte esterase and/or nitrate urinalysis by dipstick.
Scientists at the University of Kent (Chatham, UK) obtained bladder biopsies from local hospitals, and a catheter specimen of urine (CSU) was obtained from female patients and a MSU from male patients and non-OAB controls. All urine samples obtained were sent for conventional urinalysis and bacteria culture at the time of collection, if a UTI was subsequently identified the sample was retrospectively removed from the study.
The bladder biopsies were sectioned and stained and the morphological characteristics of the tissue evaluated. A DM4000B upright light microscope (Leica, Wetlar, Germany) was used to image the sections. A Luciferin Luciferase Adenosine triphosphate (ATP) Bioluminiscence Assay Kit was used to quantify ATP release from intact, live, bladder urothelium. ATP-evoked luminescence was quantified using a Synergy 2 luminometer (BioTek, Winooski, USA). The scientists also performed biopsy vesicle staining, biopsy ribonucleic acid (RNA) extraction and polymerase chain reactions, urine sediment immunofluorescence and urine nucleotide and nucleoside quantification.
The team found that some OAB patients had a low-grade inflammation, which is missed by conventional tests. This low-grade inflammation may ultimately result in increased sensory nerve excitation and the symptoms of OAB. They also found that in these patients the low-grade inflammation is associated with bacteria living inside the bladder wall. This was an observational study which means that no conclusions can be drawn about cause and effect. However, the findings may prompt the clinical re-classification of OAB and inform future therapeutic strategies. These might include protracted treatment with antibiotics to alleviate the symptoms of OAB in some individuals. The study was published on June 29, 2016, in the American Journal of Physiology.
Related Links:
University of Kent
Leica
BioTek
Latest Microbiology News
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia
- Rapid AST Platform Provides Targeted Therapeutic Results Days Faster Than Current Standard of Care
- New Analysis Method Detects Pathogens in Blood Faster and More Accurately by Melting DNA
- Rapid Sepsis Test Delivers Two Days Faster Results
- Portable Rapid PCR Diagnostic to Detect Gonorrhea and Antibiotic Susceptibility